Start Over

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.

Authors :: Yan C
Yang H
Su P
Li X
Li Z
Wang D
Zang Y
Wang T
Liu Z
Bao Z
Dong S
Zhuang T
Zhu J
Ding Y
Source :: Oncogene [Oncogene] 2022 Nov; Vol. 41 (48), pp. 5186-5198. Date of Electronic Publication: 2022 Oct 21.
Publication Year :: 2022
Abstract: Gastric cancer is one of the most lethal human malignancies in the world. Although great efforts are put in developing novel therapeutic targets, the effective targeting drugs are still limited. Recent studies reveal the abnormality of Hippo/YAP axis play critical role in the oncogenic process of gastric cancer. It is of great importance to demonstrate the regulation of Hippo signaling activity and YAP protein turnover in gastric cancer. Besides, the phosphorylation cascade on YAP function, which has been thoroughly investigated, the ubiquitination of YAP is also important in Hippo signaling status. Here, We utilized the DUB (Deubiquitinase) siRNA library to identify critical DUB for Hippo signaling. We discovered OTUB1 as a critical factor to facilitate gastric cancer cell stemness and progression, which deubiquitinated and stabilized YAP protein. The clinical data analysis implicated OTUB1 was higher expressed in gastric cancer, which correlated with YAP activity and poor survival. OUTB1 interacted with YAP protein via its OTU domain (Ovarian tumor domain) and deubiquitinated YAP at several lysine sites (K90, K280, K343, K494 and K497), which subsequently inhibited YAP degradation. Our study revealed a novel deubiquitinase of Hippo/YAP axis and one possible therapeutic target for YAP-driven gastric cancer.<br /> (© 2022. The Author(s).)